-
公开(公告)号:US09539250B2
公开(公告)日:2017-01-10
申请号:US14612879
申请日:2015-02-03
Applicant: AbbVie Inc.
Inventor: Geoff G. Z. Zhang , Michael F. Bradley , David M. Barnes , Rodger Henry
IPC: A61K31/4709 , C07D401/14 , C07C31/26 , A61K47/02 , A61K47/12
CPC classification number: C07D401/14 , A61K31/4709 , A61K47/02 , A61K47/12 , C07C31/26
Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
Abstract translation: 公开了药物的结晶形式,其制备方法,含有它的组合物以及治疗疾病的方法以及使用其抑制不良生理事件。
-
公开(公告)号:US08969569B2
公开(公告)日:2015-03-03
申请号:US14175621
申请日:2014-02-07
Applicant: AbbVie Inc.
Inventor: Geoff G. Z. Zhang , Michael F. Bradley , David M. Barnes , Rodger Henry
IPC: C07D215/38 , A61K31/04 , C07D401/14 , C07C31/26
CPC classification number: C07D401/14 , A61K31/4709 , A61K47/02 , A61K47/12 , C07C31/26
Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
Abstract translation: 公开了药物的结晶形式,其制备方法,含有它的组合物以及治疗疾病的方法以及使用其抑制不良生理事件。
-
公开(公告)号:US10329276B2
公开(公告)日:2019-06-25
申请号:US15844904
申请日:2017-12-18
Applicant: AbbVie Inc.
Inventor: Geoff G. Z. Zhang , Michael F. Bradley , David M. Barnes , Rodger Henry
IPC: C07D401/14 , C07C31/26 , A61K31/4709 , A61K47/02 , A61K47/12
Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
-
公开(公告)号:US09873681B2
公开(公告)日:2018-01-23
申请号:US15359734
申请日:2016-11-23
Applicant: AbbVie Inc.
Inventor: Geoff G. Z. Zhang , Michael F. Bradley , David M. Barnes , Rodger Henry
IPC: C07D401/14 , C07C31/26 , A61K31/4709 , A61K47/02 , A61K47/12
CPC classification number: C07D401/14 , A61K31/4709 , A61K47/02 , A61K47/12 , C07C31/26
Abstract: A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
-
-
-